Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.
Identifieur interne : 000221 ( Main/Exploration ); précédent : 000220; suivant : 000222Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.
Auteurs : Anne Hackenberg [Allemagne] ; Gökhan Arman-Kalcek ; Jens Hiller ; Gülsah GabrielSource :
- Medical microbiology and immunology [ 1432-1831 ] ; 2013.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Anticorps antiviraux (sang), Facteurs âges (MeSH), Femelle (MeSH), Grippe humaine (immunologie), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Sous-type H1N1 du virus de la grippe A (immunologie), Sujet âgé (MeSH), Études séroépidémiologiques (MeSH).
- MESH :
- immunologie : Grippe humaine, Sous-type H1N1 du virus de la grippe A.
- sang : Anticorps antiviraux.
- épidémiologie : Allemagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs âges, Femelle, Humains, Jeune adulte, Mâle, Sujet âgé, Études séroépidémiologiques.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Factors (MeSH), Aged (MeSH), Antibodies, Viral (blood), Female (MeSH), Germany (epidemiology), Humans (MeSH), Influenza A Virus, H1N1 Subtype (immunology), Influenza, Human (epidemiology), Influenza, Human (immunology), Male (MeSH), Middle Aged (MeSH), Seroepidemiologic Studies (MeSH), Young Adult (MeSH).
- MESH :
- chemical , blood : Antibodies, Viral.
- geographic , epidemiology : Germany.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza, Human.
- Adolescent, Adult, Age Factors, Aged, Female, Humans, Male, Middle Aged, Seroepidemiologic Studies, Young Adult.
Abstract
Location- and age-specific prevalence of antibodies against 2009 pandemic influenza A (H1N1) virus were determined in sera of blood donors collected during winter 2010/2011 in Germany. Prevalence of antibodies at protective titres (HI ≥1:40) varied significantly between cities (24.13-83.67 %) throughout all age groups. However, high level antibodies (HI >1:80) were most prevalent among young individuals (18-29 and 30-39 years). Overall, this study demonstrates that older people (50-59 and 60-70 years) are no longer more likely to present protective antibody titres against 2009 pandemic influenza A (H1N1) virus than younger individuals. Furthermore, our data show a highly variable immunity among the German population in different major cities almost 2 years after the detection of first cases in Germany.
DOI: 10.1007/s00430-012-0251-4
PubMed: 22684725
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.</title><author><name sortKey="Hackenberg, Anne" sort="Hackenberg, Anne" uniqKey="Hackenberg A" first="Anne" last="Hackenberg">Anne Hackenberg</name><affiliation wicri:level="3"><nlm:affiliation>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Arman Kalcek, Gokhan" sort="Arman Kalcek, Gokhan" uniqKey="Arman Kalcek G" first="Gökhan" last="Arman-Kalcek">Gökhan Arman-Kalcek</name></author><author><name sortKey="Hiller, Jens" sort="Hiller, Jens" uniqKey="Hiller J" first="Jens" last="Hiller">Jens Hiller</name></author><author><name sortKey="Gabriel, Gulsah" sort="Gabriel, Gulsah" uniqKey="Gabriel G" first="Gülsah" last="Gabriel">Gülsah Gabriel</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:22684725</idno><idno type="pmid">22684725</idno><idno type="doi">10.1007/s00430-012-0251-4</idno><idno type="wicri:Area/Main/Corpus">000240</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000240</idno><idno type="wicri:Area/Main/Curation">000240</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000240</idno><idno type="wicri:Area/Main/Exploration">000240</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.</title><author><name sortKey="Hackenberg, Anne" sort="Hackenberg, Anne" uniqKey="Hackenberg A" first="Anne" last="Hackenberg">Anne Hackenberg</name><affiliation wicri:level="3"><nlm:affiliation>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Arman Kalcek, Gokhan" sort="Arman Kalcek, Gokhan" uniqKey="Arman Kalcek G" first="Gökhan" last="Arman-Kalcek">Gökhan Arman-Kalcek</name></author><author><name sortKey="Hiller, Jens" sort="Hiller, Jens" uniqKey="Hiller J" first="Jens" last="Hiller">Jens Hiller</name></author><author><name sortKey="Gabriel, Gulsah" sort="Gabriel, Gulsah" uniqKey="Gabriel G" first="Gülsah" last="Gabriel">Gülsah Gabriel</name></author></analytic><series><title level="j">Medical microbiology and immunology</title><idno type="eISSN">1432-1831</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Factors (MeSH)</term><term>Aged (MeSH)</term><term>Antibodies, Viral (blood)</term><term>Female (MeSH)</term><term>Germany (epidemiology)</term><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Seroepidemiologic Studies (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Anticorps antiviraux (sang)</term><term>Facteurs âges (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sujet âgé (MeSH)</term><term>Études séroépidémiologiques (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Seroepidemiologic Studies</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs âges</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Sujet âgé</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Location- and age-specific prevalence of antibodies against 2009 pandemic influenza A (H1N1) virus were determined in sera of blood donors collected during winter 2010/2011 in Germany. Prevalence of antibodies at protective titres (HI ≥1:40) varied significantly between cities (24.13-83.67 %) throughout all age groups. However, high level antibodies (HI >1:80) were most prevalent among young individuals (18-29 and 30-39 years). Overall, this study demonstrates that older people (50-59 and 60-70 years) are no longer more likely to present protective antibody titres against 2009 pandemic influenza A (H1N1) virus than younger individuals. Furthermore, our data show a highly variable immunity among the German population in different major cities almost 2 years after the detection of first cases in Germany.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22684725</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1831</ISSN><JournalIssue CitedMedium="Internet"><Volume>202</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Medical microbiology and immunology</Title><ISOAbbreviation>Med. Microbiol. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.</ArticleTitle><Pagination><MedlinePgn>87-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00430-012-0251-4</ELocationID><Abstract><AbstractText>Location- and age-specific prevalence of antibodies against 2009 pandemic influenza A (H1N1) virus were determined in sera of blood donors collected during winter 2010/2011 in Germany. Prevalence of antibodies at protective titres (HI ≥1:40) varied significantly between cities (24.13-83.67 %) throughout all age groups. However, high level antibodies (HI >1:80) were most prevalent among young individuals (18-29 and 30-39 years). Overall, this study demonstrates that older people (50-59 and 60-70 years) are no longer more likely to present protective antibody titres against 2009 pandemic influenza A (H1N1) virus than younger individuals. Furthermore, our data show a highly variable immunity among the German population in different major cities almost 2 years after the detection of first cases in Germany.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hackenberg</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arman-Kalcek</LastName><ForeName>Gökhan</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hiller</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Gülsah</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Microbiol Immunol</MedlineTA><NlmUniqueID>0314524</NlmUniqueID><ISSNLinking>0300-8584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22684725</ArticleId><ArticleId IdType="doi">10.1007/s00430-012-0251-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2010 Sep 07;5(9):e12562</Citation><ArticleIdList><ArticleId IdType="pubmed">20830210</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 10;471(7337):157-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21390107</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2012 Feb;18(2):177-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21635661</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Apr 14;303(14):1383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20388894</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 May 23;29(23):4008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21463683</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1467-71</Citation><ArticleIdList><ArticleId IdType="pubmed">22065279</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Dec 09;15(49):null</Citation><ArticleIdList><ArticleId IdType="pubmed">21163179</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(9):e23955</Citation><ArticleIdList><ArticleId IdType="pubmed">21915270</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2010 May;199(2):117-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20162304</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2009 Jun;58(6):446-58</Citation><ArticleIdList><ArticleId IdType="pubmed">19446340</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2011 Jan 18;2:156</Citation><ArticleIdList><ArticleId IdType="pubmed">21245837</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jun 19;324(5934):1557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19433588</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2010 Sep;82(9):1617-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20648619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2009 Jul 10;325(5937):197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">19465683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2010 Jan;48(1):290-1</Citation><ArticleIdList><ArticleId IdType="pubmed">19889892</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Feb 09;6(2):e16809</Citation><ArticleIdList><ArticleId IdType="pubmed">21347418</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Oct 07;15(40):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20946757</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Dec 16;15(50):null</Citation><ArticleIdList><ArticleId IdType="pubmed">21172169</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Jun 17;15(24):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20576237</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2011 Aug;18(8):1205-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21653743</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Jul 29;15(30):null</Citation><ArticleIdList><ArticleId IdType="pubmed">20684814</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Jan 12;17(2):null</Citation><ArticleIdList><ArticleId IdType="pubmed">22264864</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2010 Jun 07;10:155</Citation><ArticleIdList><ArticleId IdType="pubmed">20525408</ArticleId></ArticleIdList></Reference><Reference><Citation>Infection. 2011 Apr;39(2):101-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21424756</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Hambourg</li></region><settlement><li>Hambourg</li></settlement></list><tree><noCountry><name sortKey="Arman Kalcek, Gokhan" sort="Arman Kalcek, Gokhan" uniqKey="Arman Kalcek G" first="Gökhan" last="Arman-Kalcek">Gökhan Arman-Kalcek</name><name sortKey="Gabriel, Gulsah" sort="Gabriel, Gulsah" uniqKey="Gabriel G" first="Gülsah" last="Gabriel">Gülsah Gabriel</name><name sortKey="Hiller, Jens" sort="Hiller, Jens" uniqKey="Hiller J" first="Jens" last="Hiller">Jens Hiller</name></noCountry><country name="Allemagne"><region name="Hambourg"><name sortKey="Hackenberg, Anne" sort="Hackenberg, Anne" uniqKey="Hackenberg A" first="Anne" last="Hackenberg">Anne Hackenberg</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000221 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000221 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22684725
|texte= Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22684725" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |